Interview Hard-to-treat cancers becoming treatable thanks to Ambagon Therapeutics

Press/Media: Expert Comment

Period	7 Oct 2022

Media coverage

Title	Interview Hard-to-treat cancers becoming treatable thanks to Ambagon Therapeutics
Media name/outlet	Innovation Origins
Country/Territory	Netherlands
Date	7/10/22
URL	https://innovationorigins.com/en/hard-to-treat-cancers-becoming-treatable-thanks-to-ambagon-therapeutics/
Persons	Luc Brunsveld, Christian Ottmann